Docetaxel 80mg/4ml Injection – Global Export Supply by Cordium Pharmaceuticals Pvt Ltd (India)
Cordium Pharmaceuticals Pvt Ltd is a leading India-based global exporter of Docetaxel 80mg/4ml Injection, supplying high-quality oncology medicines with fast international delivery to major markets including:
United States, Germany, United Kingdom, Netherlands, South Africa, United Arab Emirates, and Brazil.
Our products are manufactured under strict quality standards to support global healthcare and oncology treatment requirements.
About Docetaxel 80mg/4ml Injection
Docetaxel is a chemotherapy medication (taxane class) used in the treatment of various cancers. It works by inhibiting cancer cell division and slowing tumor growth.
Common Medical Uses:
Breast cancer
Non-small cell lung cancer (NSCLC)
Prostate cancer
Gastric (stomach) cancer
Head and neck cancers
Dosage Information (General Medical Guidance)
⚠️ Dosage must always be determined by a qualified oncologist.
Administered as intravenous (IV) infusion
Common dosing range: 60–100 mg/m² every 3 weeks, depending on cancer type and patient condition
May be used alone or in combination therapy
Possible Side Effects
Patients may experience some side effects during treatment, including:
Low white blood cell count (neutropenia)
Fatigue and weakness
Nausea and vomiting
Hair loss (alopecia)
Fluid retention
Mouth sores
Allergic reactions (rare but serious)
Medical supervision is required during treatment.
Global Export & Supply Advantage
Cordium Pharmaceuticals Pvt Ltd ensures:
Fast international shipping & logistics support
WHO-GMP quality standards
Secure packaging & compliance documentation
Bulk export supply capability
Reliable pharmaceutical sourcing from India
Contact Information
📱 WhatsApp: +91-9405117673
📧 Email: info@cordiumpharma.com
For global wholesale inquiries, partnerships, and export requirements, contact our team for quick response and quotations.
